Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Makvandi

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian CancerAnthony J Young, Austin R Pantel, Varsha Viswanath, et al.
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation|March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancerMehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
JCI Insight|January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancersErin George, Hyoung Kim, Clemens Krepler, et al.
Communications Biology|November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastomaMehran Makvandi, Minu Samanta, Paul Martorano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian CancerAnthony J Young, Austin R Pantel, Varsha Viswanath, et al.
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation|March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancerMehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
JCI Insight|January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancersErin George, Hyoung Kim, Clemens Krepler, et al.
Communications Biology|November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastomaMehran Makvandi, Minu Samanta, Paul Martorano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 4